Home / Publication / Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor

論文

Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor

Author(s): Neeraj Gupta, Michael J. Hanley, Paul M. Diderichsen, Huyuan Yang, Alice Ke, Zhaoyang Teng, Richard Labotka, Deborah Berg, Chirag Patel, Guohui Liu, Helgi van de Velde, Karthik Venkatakrishnan

Year: 2018年2月15日

How Model-informed drug development rescue projects from a risky situation

事例紹介

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

論文

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

ウェビナー

How a budget-impact analysis complements cost-effectiveness to present a balanced economic outlook

ブログ

Powered by Translations.com GlobalLink Web Software

Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor

Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor

How Model-informed drug development rescue projects from a risky situation

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

How a budget-impact analysis complements cost-effectiveness to present a balanced economic outlook

メルマガ登録

クイックアクセス

ソリューション

お問合せ

Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor

How Model-informed drug development rescue projects from a risky situation​

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

How a budget-impact analysis complements cost-effectiveness to present a balanced economic outlook

メルマガ登録

クイックアクセス

ソリューション

お問合せ

How Model-informed drug development rescue projects from a risky situation